Shareholdings
| Concept |
As at 2024-12-31 |
As at 2023-12-31 |
|---|---|---|
| Shareholdings | ||
| Reporting company | ||
| Details of specified investment shares held for purposes other than pure investment | ||
| Issue |
RayzeBio, Inc.
|
— |
| Number of shares |
xbrli:shares
|
1,163,579
xbrli:shares
|
| Carrying amount |
JPY
|
10,259,217,000
JPY
|
| Purpose of shareholding, overview of business alliance, quantitative effects of shareholding and reason for increase in number of shares |
(保有目的)放射性医薬品に係る戦略的共同研究開発関係の強化のため(株式数が減少した理由)当事業年度にBristol Myers Squibb Companyによる公開買付が実施され、この公開買付に応じたことにより株式を売却しています。
|
— |
| Whether issuer of aforementioned shares holds reporting company's shares |
無
|
— |